Catalyst Pharmaceuticals Inc (CPRX)
Operating return on assets (Operating ROA)
| Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | ||
|---|---|---|---|---|---|---|
| Operating income | US$ in thousands | 195,124 | 86,812 | 101,838 | 52,385 | 41,303 |
| Total assets | US$ in thousands | 851,411 | 470,114 | 375,630 | 237,788 | 192,354 |
| Operating ROA | 22.92% | 18.47% | 27.11% | 22.03% | 21.47% |
December 31, 2024 calculation
Operating ROA = Operating income ÷ Total assets
= $195,124K ÷ $851,411K
= 22.92%
Catalyst Pharmaceuticals Inc's operating return on assets (operating ROA) has shown fluctuations over the five-year period from December 31, 2020, to December 31, 2024. The operating ROA was 21.47% in 2020, increased to 22.03% in 2021, significantly rose to 27.11% in 2022, dropped to 18.47% in 2023, and then rebounded to 22.92% in 2024.
The upward trend in operating ROA from 2020 to 2022 indicates an improvement in the company's ability to generate operating profit from its assets. However, the decline in 2023 followed by a recovery in 2024 suggests some volatility or challenges in managing assets efficiently.
Overall, Catalyst Pharmaceuticals Inc's operating ROA performance demonstrates a mix of strengths and potential areas for improvement, highlighting the importance of sustained efficient asset utilization to drive profitability in the long term.
Peer comparison
Dec 31, 2024